XENE Xenon Pharmaceuticals Inc

USD 43.00 0.34 0.797
Icon

Xenon Pharmaceuticals Inc (XENE) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 43.00

+0.34 (+0.80)%

USD 3.30B

0.44M

USD 56.75(+31.98%)

USD 30.00 (-30.23%)

Icon

XENE

Xenon Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 43.00
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.30B

USD 30.00 (-30.23%)

USD 43.00

Xenon Pharmaceuticals Inc (XENE) Stock Forecast

Show ratings and price targets of :
USD 56.75
(+31.98%)

Based on the Xenon Pharmaceuticals Inc stock forecast from 7 analysts, the average analyst target price for Xenon Pharmaceuticals Inc is USD 56.75 over the next 12 months. Xenon Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Xenon Pharmaceuticals Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Xenon Pharmaceuticals Inc’s stock price was USD 43.00. Xenon Pharmaceuticals Inc’s stock price has changed by -1.80% over the past week, -13.36% over the past month and +24.85% over the last year.

No recent analyst target price found for Xenon Pharmaceuticals Inc
No recent average analyst rating found for Xenon Pharmaceuticals Inc

Company Overview Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, a Kv7 potassium channel opener that is Phase III clinical trials ...Read More

3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8

251

December

USD

USA

Adjusted Closing Price for Xenon Pharmaceuticals Inc (XENE)

Loading...

Unadjusted Closing Price for Xenon Pharmaceuticals Inc (XENE)

Loading...

Share Trading Volume for Xenon Pharmaceuticals Inc Shares

Loading...

Compare Performance of Xenon Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for XENE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Xenon Pharmaceuticals Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing XENE

Symbol Name XENE's Weight Expense Ratio Price(Change) Market Cap
IBRN
iShares Trust - iShares N.. 4.08 % 0.47 % +0.48 (+1.90%) USD3.86M

Frequently Asked Questions About Xenon Pharmaceuticals Inc (XENE) Stock

Based on ratings from 7 analysts Xenon Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 9 buy, sell and hold ratings.

Unfortunately we do not have enough data on XENE's stock to indicate if its a good dividend stock.

Based on targets from 7 analysts, the average taret price for XENE is USD 56.75 over the next 12 months. The maximum analyst target price is USD 63 while the minimum anlayst target price is USD 46.

Unfortunately we do not have enough data on XENE's stock to indicate if its overvalued.

The last closing price of XENE's stock was USD 43.00.

The most recent market capitalization for XENE is USD 3.30B.

Based on targets from 7 analysts, the average taret price for XENE is projected at USD 56.75 over the next 12 months. This means that XENE's stock price may go up by +31.98% over the next 12 months.

Following are ETFs with the highest allocation to Xenon Pharmaceuticals Inc's stock :

IBRN

As per our most recent records Xenon Pharmaceuticals Inc has 251 Employees.

Xenon Pharmaceuticals Inc's registered address is 3650 Gilmore Way, Burnaby, BC, Canada, V5G 4W8. You can get more information about it from Xenon Pharmaceuticals Inc's website at https://www.xenon-pharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...